Loading clinical trials...
Loading clinical trials...
Phase II Study Treatment of High Risk Non-Hodgkin's Lymphomas
Conditions
Interventions
CEEP regimen
Tandem high-dose therapy (HDT) followed by autologous peripheral blood stem cell (PBSC)
Locations
1
France
Emmanuel Gyan
Tours, France
Start Date
October 1, 1994
Primary Completion Date
July 1, 1999
Completion Date
February 1, 2009
Last Updated
March 25, 2009
NCT07388563
NCT05529069
NCT06337318
NCT06263491
NCT05139017
NCT07350863
Lead Sponsor
French Innovative Leukemia Organisation
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions